Home / Publications / Natural chlorins as a promising platform for creating targeted theranostics in oncology

Natural chlorins as a promising platform for creating targeted theranostics in oncology

Mikhail Alexandrovich Grin 1
Mikhail Alexandrovich Grin
Nikita Vladimirovich Suvorov 1
Nikita Vladimirovich Suvorov
Andrey Fedorovich Mironov 1
Andrey Fedorovich Mironov
Published 2020-06-26
Focus articleVolume 30, Issue 4, 406-418
12
Share
Cite this
GOST
 | 
Cite this
GOST Copy
Grin M. A., Suvorov N. V., Mironov A. F. Natural chlorins as a promising platform for creating targeted theranostics in oncology // Mendeleev Communications. 2020. Vol. 30. No. 4. pp. 406-418.
GOST all authors (up to 50) Copy
Grin M. A., Suvorov N. V., Mironov A. F. Natural chlorins as a promising platform for creating targeted theranostics in oncology // Mendeleev Communications. 2020. Vol. 30. No. 4. pp. 406-418.
RIS
 | 
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mencom.2020.07.003
UR - https://mendcomm.colab.ws/publications/10.1016/j.mencom.2020.07.003
TI - Natural chlorins as a promising platform for creating targeted theranostics in oncology
T2 - Mendeleev Communications
AU - Grin, Mikhail Alexandrovich
AU - Suvorov, Nikita Vladimirovich
AU - Mironov, Andrey Fedorovich
PY - 2020
DA - 2020/06/26
PB - Mendeleev Communications
SP - 406-418
IS - 4
VL - 30
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors) Copy
@article{2020_Grin,
author = {Mikhail Alexandrovich Grin and Nikita Vladimirovich Suvorov and Andrey Fedorovich Mironov},
title = {Natural chlorins as a promising platform for creating targeted theranostics in oncology},
journal = {Mendeleev Communications},
year = {2020},
volume = {30},
publisher = {Mendeleev Communications},
month = {Jun},
url = {https://mendcomm.colab.ws/publications/10.1016/j.mencom.2020.07.003},
number = {4},
pages = {406--418},
doi = {10.1016/j.mencom.2020.07.003}
}
MLA
Cite this
MLA Copy
Grin, Mikhail Alexandrovich, et al. “Natural chlorins as a promising platform for creating targeted theranostics in oncology.” Mendeleev Communications, vol. 30, no. 4, Jun. 2020, pp. 406-418. https://mendcomm.colab.ws/publications/10.1016/j.mencom.2020.07.003.
Views / Downloads
1 / 8

Keywords

bacteriochlorins
chlorins
fluorescence diagnostics
nanoparticles
photodynamic therapy
targeted photosensitizers

Abstract

This review deals with the progress in the chemistry of natural chlorins and the prospects of using their derivatives as theranostics. Particular attention is paid to the creation of targeted photosensitizers by addition of vector molecules to chlorins and bacteriochlorins, or by immobilization onto nanoparticles of various nature. The results of biological tests that establish relationship between the structure, antitumor activity, and diagnostic potential of the resulting photosensitizers are presented.

References

1.
10.1016/j.mencom.2020.07.003_bib0005
Bonnett
Chemical Aspects of Photodynamic Therapy, 2000
2.
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
Celli J.P., Spring B.Q., Rizvi I., Evans C.L., Samkoe K.S., Verma S., Pogue B.W., Hasan T.
Chemical Reviews, 2010
3.
Photodynamic therapy of cancer: An update
Agostinis P., Berg K., Cengel K.A., Foster T.H., Girotti A.W., Gollnick S.O., Hahn S.M., Hamblin M.R., Juzeniene A., Kessel D., Korbelik M., Moan J., Mroz P., Nowis D., Piette J., et. al.
Ca-A Cancer Journal for Clinicians, 2011
4.
Photodynamic therapy (PDT) of cancer: from local to systemic treatment
Dabrowski J.M., Arnaut L.G.
Photochemical and Photobiological Sciences, 2015
5.
Photodynamic Therapy
Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., Moan J., Peng Q.
Journal of the National Cancer Institute, 1998
7.
10.1016/j.mencom.2020.07.003_bib0035
Pushpan
Curr. Med. Chem.: Anti-Cancer Agents, 2002
8.
Dye Sensitizers for Photodynamic Therapy
Ormond A., Freeman H.
Materials, 2013
9.
New photosensitizers for photodynamic therapy
Abrahamse H., Hamblin M.
Biochemical Journal, 2016
10.
10.1016/j.mencom.2020.07.003_bib0050
Mironov
Itogi Nauki i Tekhniki. Sovremennie Problemy Lazernoi Fiziki, 1989
11.
10.1016/j.mencom.2020.07.003_bib0055
Moan
Photodynamic Therapy, 2003
12.
Toxicity of photodynamic therapy with LED associated to Photogem®: An in vivo study
Trindade F.Z., Pavarina A.C., Ribeiro A.P., Bagnato V.S., Vergani C.E., de Souza Costa C.A.
Lasers in Medical Science, 2011
13.
Photophysical properties of sinoporphyrin sodium and explanation of its high photo-activity
Zang L., Zhao H., Fang Q., Fan M., Chen T., Tian Y., Yao J., Zheng Y., Zhang Z., Cao W.
Journal of Porphyrins and Phthalocyanines, 2017
15.
2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: Implications for photodynamic therapy
Lobel J., MacDonald I.J., Ciesielski M.J., Barone T., Potter W.R., Pollina J., Plunkett R.J., Fenstermaker R.A., Dougherty T.J.
Lasers in Surgery and Medicine, 2001
16.
10.1016/j.mencom.2020.07.003_bib0080
Partrice
Photodynamic Therapy, 2003
17.
In vitro studies of the antiherpetic effect of photodynamic therapy
Zverev V.V., Makarov O.V., Khashukoeva A.Z., Svitich O.A., Dobrokhotova Y.E., Markova E.A., Labginov P.A., Khlinova S.A., Shulenina E.A., Gankovskaya L.V.
Lasers in Medical Science, 2016
18.
Photodynamic therapy for cancer
Dolmans D.E., Fukumura D., Jain R.K.
Nature Reviews Cancer, 2003
19.
Photobiological properties of phthalocyanine photosensitizers Photosens, Holosens and Phthalosens: A comparative in vitro analysis
Brilkina A.A., Dubasova L.V., Sergeeva E.A., Pospelov A.J., Shilyagina N.Y., Shakhova N.M., Balalaeva I.V.
Journal of Photochemistry and Photobiology B: Biology, 2019
20.
Determination of the in vivo pharmacokinetics of palladium-bacteriopheophorbide (WST09) in EMT6 tumour-bearing Balb/c mice using graphite furnace atomic absorption spectroscopy
21.
Preclinical Study of the Novel Vascular Occluding Agent, WST11, for Photodynamic Therapy of the Canine Prostate
Chevalier S., Anidjar M., Scarlata E., Hamel L., Scherz A., Ficheux H., Borenstein N., Fiette L., Elhilali M.
Journal of Urology, 2011
22.
TOOKAD ® soluble VTP: From local tumor ablation to systemic cancer control
Scherz A., Salomon Y., Coleman J.
Photodiagnosis and Photodynamic Therapy, 2017
24.
Antibody–Drug Conjugates for Cancer Therapy
Parslow A., Parakh S., Lee F., Gan H., Scott A.
Biomedicines, 2016
26.
Safety, Pharmacokinetics, and Activity of GRN1005, a Novel Conjugate of Angiopep-2, a Peptide Facilitating Brain Penetration, and Paclitaxel, in Patients with Advanced Solid Tumors
Kurzrock R., Gabrail N., Chandhasin C., Moulder S., Smith C., Brenner A., Sankhala K., Mita A., Elian K., Bouchard D., Sarantopoulos J.
Molecular Cancer Therapeutics, 2012
27.
Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsin
28.
Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors
Manzoor A.A., Lindner L.H., Landon C.D., Park J., Simnick A.J., Dreher M.R., Das S., Hanna G., Park W., Chilkoti A., Koning G.A., ten Hagen T.L., Needham D., Dewhirst M.W.
Cancer Research, 2012
31.
The synthesis of galactopyranosyl-substituted derivatives of pheophorbide
Aksenova A.A., Sebyakin Y.L., Mironov A.F.
Russian Journal of Bioorganic Chemistry, 2000
32.
Synthesis and Properties of O- and S-Glycosylated Derivatives of Pyropheophorbide a
Aksenova A.A., Sebyakin Y.L., Mironov A.F.
Russian Journal of Bioorganic Chemistry, 2001
33.
Lebedeva V.S., Ruziev R.D., Popov A.V., Sebyakin Y.L., Mironov A.F.
Mendeleev Communications, 2007
34.
Cyclic N-hydroxyimides in a series of chlorins and porphyrins
35.
Grin M.A., Lonin I.S., Makarov A.I., Lakhina A.A., Toukach F.V., Kachala V.V., Orlova A.V., Mironov A.F.
Mendeleev Communications, 2008
36.
10.1016/j.mencom.2020.07.003_bib0180
Lonin
J. Porphyrins Phthalocyanines, 2008
37.
1,3-dipolar cycloaddition in the synthesis of glycoconjugates of natural chlorins and bacteriochlorins
Grin M.A., Lonin I.S., Lakhina A.A., Ol'shanskaya E.S., Makarov A.I., Sebyakin Y.L., Guryeva L.Y., Toukach P.V., Kononikhin A.S., Kuzmin V.A., Mironov A.F.
Journal of Porphyrins and Phthalocyanines, 2009
38.
Purpurinimide Carbohydrate Conjugates:  Effect of the Position of the Carbohydrate Moiety in Photosensitizing Efficacy
Pandey S.K., Zheng X., Morgan J., Missert J.R., Liu T., Shibata M., Bellnier D.A., Oseroff A.R., Henderson B.W., Dougherty T.J., Pandey R.K.
Molecular Pharmaceutics, 2007
39.
Lonin I.S., Grin M.A., Lakhina A.A., Mironov A.F.
Mendeleev Communications, 2012
40.
10.1016/j.mencom.2020.07.003_bib0200
Plotnikova
Rossiiskii Bioterapevticheskii Zhurnal, 2012
41.
"Click chemistry" in the synthesis of the first glycoconjugates of bacteriochlorin series
Grin M.A., Lonin I.S., Likhosherstov L.M., Novikova O.S., Plyutinskaya A.D., Plotnikova E.A., Kachala V.V., Yakubovskaya R.I., Mironov A.F.
Journal of Porphyrins and Phthalocyanines, 2012
42.
Sensitizers of second generation for photodynamic therapy of cancer based on chlorophyll and bacteriochlorophyll derivatives
Mironov A.F., Kozyrev A.N., Brandis A.S.
Proceedings of SPIE - The International Society for Optical Engineering, 1993
43.
New bacteriochlorin derivatives with a fused N-aminoimide ring
Mironov A.F., Grin M.A., Tsiprovskiy A.G., Kachala V.V., Karmakova T.A., Plyutinskaya A.D., Yakubovskaya R.I.
Journal of Porphyrins and Phthalocyanines, 2009
44.
Synthesis and biological evaluation of hydroxamate-Based inhibitors of glutamate carboxypeptidase II.
Stoermer D., Liu Q., Hall M.R., Flanary J.M., Thomas A.G., Rojas C., Slusher B.S., Tsukamoto T.
Bioorganic and Medicinal Chemistry Letters, 2003
45.
Synthesis and Biological Analysis of Prostate-Specific Membrane Antigen-Targeted Anticancer Prodrugs
Kularatne S.A., Venkatesh C., Santhapuram H.R., Wang K., Vaitilingam B., Henne W.A., Low P.S.
Journal of Medicinal Chemistry, 2010
46.
99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer
Hillier S.M., Maresca K.P., Lu G., Merkin R.D., Marquis J.C., Zimmerman C.N., Eckelman W.C., Joyal J.L., Babich J.W.
Journal of Nuclear Medicine, 2013
47.
M. A. Grin, N.V. Suvorov, A.E. Machulkin, E.A. Plotnikova, R.I. Yakubovskaya, A.G. Majouga, A.F. Mironov and E. V. Filonenko, Patent RU 2670087C1, 2018.
48.
Mono‐(l)‐aspartylchlorin‐e6 † ‡
Hargus J.A., Fronczek F.R., Vicente M.G., Smith K.M.
Photochemistry and Photobiology, 2007
49.
Synthesis of PSMA-targeted 131- and 152-substituted chlorin e6 derivatives and their biological properties
Suvorov N.V., Machulkin A.E., Ivanova A.V., Popkov A.M., Bondareva E.A., Plotnikova E.A., Yakubovskaya R.I., Majouga A.G., Mironov A.F., Grin M.A.
Journal of Porphyrins and Phthalocyanines, 2018
50.
51.
Inverse electron demand Diels-Alder reactions in chemical biology.
Oliveira B.L., Guo Z., Bernardes G.J.
Chemical Society Reviews, 2017
52.
Cycloimide bacteriochlorin p derivatives: photodynamic properties and cellular and tissue distribution.
Sharonov G.V., Karmakova T.A., Kassies R., Pljutinskaya A.D., Grin M.A., Refregiers M., Yakubovskaya R.I., Mironov A.F., Maurizot J., Vigny P., Otto C., Feofanov A.V.
Free Radical Biology and Medicine, 2006
53.
V. I. Chissov, R.I. Yakubovskaya, A.F. Mironov, M.A. Grin, E.A. Plotnikova, N.B. Morozova and A. A. Tsygankov, Patent RU 2521327C1, 2012.
54.
Octapod iron oxide nanoparticles as high-performance T2 contrast agents for magnetic resonance imaging
Zhao Z., Zhou Z., Bao J., Wang Z., Hu J., Chi X., Ni K., Wang R., Chen X., Chen Z., Gao J.
Nature Communications, 2013
55.
Synthesis and characterization of bacteriochlorin loaded magnetic nanoparticles (MNP) for personalized MRI guided photosensitizers delivery to tumor
Ostroverkhov P.V., Semkina A.S., Naumenko V.A., Plotnikova E.A., Melnikov P.A., Abakumova T.O., Yakubovskaya R.I., Mironov A.F., Vodopyanov S.S., Abakumov A.M., Majouga A.G., Grin M.A., Chekhonin V.P., Abakumov M.A.
Journal of Colloid and Interface Science, 2019
56.
Human serum albumin as an effective coating for hydrophobic photosensitizes immobilization on magnetic nanoparticles
Ostroverkhov P., Semkina A., Nikitin A., Smirnov A., Vedenyapina D., Vlasova K., Kireev I., Grin M., Chekhonin V., Majouga A., Abakumov M.
Journal of Magnetism and Magnetic Materials, 2019
57.
Nanocarriers as an emerging platform for cancer therapy
Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R.
Nature Nanotechnology, 2007
58.
Gold nanoparticles in delivery applications☆
GHOSH P., HAN G., DE M., KIM C., ROTELLO V.
Advanced Drug Delivery Reviews, 2008
59.
Monolayer coated gold nanoparticles for delivery applications
Rana S., Bajaj A., Mout R., Rotello V.M.
Advanced Drug Delivery Reviews, 2012
61.
Novel Photosensitizer Based on Bacteriopurpurinimide and Magnetite Nanoparticles
Suvorov N.V., Grin M.A., Popkov A.M., Garanina A.S., Mironov A.F., Majouga A.G.
Macroheterocycles, 2016
62.
The golden age: gold nanoparticles for biomedicine
Dreaden E.C., Alkilany A.M., Huang X., Murphy C.J., El-Sayed M.A.
Chemical Society Reviews, 2012
63.
Theranostic Nanoshells: From Probe Design to Imaging and Treatment of Cancer
Bardhan R., Lal S., Joshi A., Halas N.J.
Accounts of Chemical Research, 2011
64.
Gold nanocages: from synthesis to theranostic applications.
Xia Y., Li W., Cobley C.M., Chen J., Xia X., Zhang Q., Yang M., Cho E.C., Brown P.K.
Accounts of Chemical Research, 2011
65.
Development of bacteriochlorophyll a-based near-infrared photosensitizers conjugated to gold nanoparticles for photodynamic therapy of cancer
Pantiushenko I.V., Rudakovskaya P.G., Starovoytova A.V., Mikhaylovskaya A.A., Abakumov M.A., Kaplan M.A., Tsygankov A.A., Majouga A.G., Grin M.A., Mironov A.F.
Biochemistry (Moscow), 2015
66.
Treatment Effects of WST11 Vascular Targeted Photodynamic Therapy for Urothelial Cell Carcinoma in Swine
Murray K.S., Winter A.G., Corradi R.B., LaRosa S., Jebiwott S., Somma A., Takaki H., Srimathveeravalli G., Lepherd M., Monette S., Kim K., Scherz A., Coleman J.A.
Journal of Urology, 2016
67.
Neuschmelting V., Kim K., Malekzadeh-Najafabadi J., Jebiwott S., Prakash J., Scherz A., Coleman J.A., Kircher M.F., Ntziachristos V.
Theranostics, 2017
68.
10.1016/j.mencom.2020.07.003_bib0340
Rashid
Rev. Roum. Chim., 2014
69.
10.1016/j.mencom.2020.07.003_bib0345
Thomsen
Image Principles, Neck, and the Brain, 2016
70.
Cyclen-based Gd3+ complexes as MRI contrast agents: Relaxivity enhancement and ligand design
Rashid H.U., Martines M.A., Jorge J., de Moraes P.M., Umar M.N., Khan K., Rehman H.U.
Bioorganic and Medicinal Chemistry, 2016
71.
Synthetic strategies for preparation of cyclen-based MRI contrast agents
Cakić N., Gündüz S., Rengarasu R., Angelovski G.
Tetrahedron Letters, 2015
72.
10.1016/j.mencom.2020.07.003_bib0360
Tóth
2003
73.
Grin M.A., Brusov S.S., Shchepelina E.Y., Ponomarev P.V., Khrenova M.K., Smirnov A.S., Lebedeva V.S., Mironov A.F.
Mendeleev Communications, 2017
74.
10.1016/j.mencom.2020.07.003_bib0370
Smirnov
Tonkie Khim. Tekhnol. (Fine Chem. Technol.), 2019